An EEG Study of Intravenous Ketamine for Major Depression Disorder

Clinical trial NCT05506462 · UNKNOWN

Trial details

NCT number: NCT05506462
Sponsor: Ehave Inc.
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2023-01-01
Primary completion: 2024-01-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.